Mice lacking alpha-synuclein are resistant to mitochondrial toxins
about
The role of oxidative stress in Parkinson's diseaseProtein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseasesElectron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial BioenergeticsMouse models of Parkinson's disease associated with mitochondrial dysfunctionGenetically engineered mouse models of Parkinson's diseaseMitochondrial dysfunction and oxidative stress in Parkinson's diseaseResistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activationModulation of alpha-synuclein expression in transgenic animals for modelling synucleinopathies--is the juice worth the squeeze?Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease modelsNitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats.Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent Neurons.The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition.Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease.Mitochondrial dysfunction in the striatum of aged chronic mouse model of Parkinson's disease.A Western-like fat diet is sufficient to induce a gradual enhancement in fat mass over generationsMitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection.Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress.TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's disease.Oxidative stress in neurodegenerationAlpha-synuclein levels in blood plasma decline with healthy aging.Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?α-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter.Mitochondrial dysfunction in genetic animal models of Parkinson's diseaseInteraction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease modelParkinson's disease and α-synuclein expressionUnderstanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.Expanding insights of mitochondrial dysfunction in Parkinson's disease.Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's diseaseDispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons.The role of mitochondria in inherited neurodegenerative diseases.Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's diseaseDeletion of Herpud1 Enhances Heme Oxygenase-1 Expression in a Mouse Model of Parkinson's Disease.Synergistic effects of environmental risk factors and gene mutations in Parkinson's disease accelerate age-related neurodegeneration.Methyl-Arginine Profile of Brain from Aged PINK1-KO+A53T-SNCA Mice Suggests Altered Mitochondrial Biogenesis.Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification.Redox imbalance in Parkinson's disease.α-Synuclein and mitochondria: partners in crime?
P2860
Q24307946-B463DEE8-CB9B-4F37-AEE9-1EC50D9A115DQ24650014-06F6D281-1011-4F4F-BD68-5941CE2C35CEQ26795417-81FDB1F2-8ED9-463F-8308-4DF75BB2F1AAQ26829851-6E25EB99-2753-4A13-BE80-2E7EA33B1015Q26852964-BDC0BF48-ADFC-4F85-8A94-0E8113136E7CQ27014051-83BC727D-9D56-4E15-A8C8-2E49159696ADQ28477043-CDBA0A14-CA2A-4A7C-BB68-6968B5F15A6DQ33392127-B4F9D5F8-AD5F-48F0-AD77-46A3A99AB8C3Q33457162-E512A14E-0A40-44F4-A7D5-3885CEB6FA0EQ33521022-ADBAAD0F-9EA7-487E-9FD1-25DFBF151037Q33553317-44EB6B42-3F8F-4593-ABDA-BBFE68CB0AD1Q33617563-A2EA0DF5-A27D-4EE9-911A-DC57A2A1CEBEQ33748087-9FE59F89-F08C-4D7F-AC09-CB7C6C52310BQ33840243-C1BA7B94-BB15-44B8-93FD-32AA22F6DAD6Q33843073-5BF50F7F-EC56-45E2-B279-CFC98D6187ACQ33868426-CDC4D162-3CF3-493D-A320-0E99754AA6B0Q33993149-26714A18-F450-4EBD-9734-5A12371CE4BFQ34460675-38B613E7-1D68-4F67-AACC-85BF9C08DFE6Q34534524-9FF62D60-F511-48E7-9A21-0A66B523143DQ34692945-F61BF2F0-E1C3-41FF-8B16-A4E454A4276FQ35224677-BBCDBD49-05E9-4A07-99C4-0334DC8CFB19Q35284843-5C0A6126-B6B0-451D-96B6-E9C4D345C735Q35412397-1E109510-7A6F-4F53-8F76-A6CDABAEC913Q35626155-5E8B64E9-6E75-4659-8C69-DB73CB7E7823Q35799109-5D44A6DD-2608-44E1-AF1A-919FD1E8F073Q35834043-D6A8082B-2AA2-4940-BEE0-BF5691E8DF8EQ36040166-C18DE211-1B1E-44FA-B170-50FCF2082DB5Q36346542-9E177775-55C1-444D-8622-10C1022F3FD3Q36372732-F3EB622D-EAC6-4344-97FA-4D6DD69690A5Q36404133-43DAA3D0-9F98-4D71-8D3D-A0487C9FE714Q36462680-A30E25C1-2BBE-4544-9810-2CE311E89E40Q36512547-D104962D-5D3B-489E-AD0F-D08CBC49C9A1Q36521932-D2182BA2-1124-4437-857E-C79EC49001BAQ36607413-B3DA4460-1254-4586-82A2-8BB5C82686B6Q36661352-212A0340-30C0-461C-AC0F-C340EE7EF21FQ36676904-BFBA9985-D943-409E-8FA1-D8E27109CE48Q36686168-7B68D280-10DB-4D84-B9E0-4983AF5B6A00Q36791338-AD5290D8-02C6-4117-A8C2-FE3720A53B23Q36899782-2EB03BED-CF93-4586-9D16-3C15EC144696Q36983221-BD99127A-872C-4308-8517-AD1DC59D856C
P2860
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
description
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im November 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/03/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/03/01)
@nl
наукова стаття, опублікована в березні 2006
@uk
مقالة علمية (نشرت في مارس 2006)
@ar
name
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
@ast
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
@en
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
@nl
type
label
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
@ast
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
@en
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
@nl
prefLabel
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
@ast
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
@en
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
@nl
P2093
P50
P921
P1476
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
@en
P2093
Asa Abeliovich
Donald Siwek
Gabrielle Gardian
Lichuan Yang
M Flint Beal
Neil W Kowall
P304
P356
10.1016/J.NBD.2005.08.018
P577
2005-11-18T00:00:00Z